BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 14, 2005
 |  BioCentury  |  Emerging Company Profile

Fovea Pharma SA

Fovea Pharma SA

Paris, France

Technology: Screening platform using primary retinal cells from animal models

Disease focus: Ophthalmic

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >